Rik Ossenkoppele
21 – 30 of 193
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Complementary utility of plasma biomarkers and Aβ-PET for diagnosis, risk-stratification, and treatment monitoring in Alzheimer's disease
- Contribution to journal › Debate/Note/Editorial
-
Mark
Frequency and Clinical Outcomes Associated with Tau Positron Emission Tomography Positivity
- Contribution to journal › Article
-
Mark
Treatment-related amyloid clearance (TRAC) : a framework to characterize patients in the era of anti-amyloid therapies
- Contribution to journal › Debate/Note/Editorial
-
Mark
Amyloid-β and tau deposition in traumatic brain injury : a study of Vietnam War veterans
- Contribution to journal › Article
-
Mark
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers : a longitudinal cohort study
- Contribution to journal › Article
-
Mark
No sex differences in the association between regional brain structure abnormalities and cognitive functioning in a geriatric memory clinic population
- Contribution to journal › Article
-
Mark
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals : implications for clinical trials
- Contribution to journal › Article
-
Mark
Characterization of individuals fulfilling clinical criteria for limbic-predominant age-related TDP43 encephalopathy (LATE) in a tertiary memory clinic
- Contribution to journal › Published meeting abstract
-
Mark
Predicting cognitive decline in amyloid-negative individuals with amnestic mild cognitive impairment
- Contribution to journal › Published meeting abstract
-
Mark
Hemispheric Asymmetry of Amyloid Deposition Influences Asymmetric Tau Pathology in Alzheimer’s Disease
- Contribution to journal › Published meeting abstract
